Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PLX	PROTALIX BIOTHERAPEUTICS INC	$239.56M	8.80%	3.70%	10.91%	17.40%	0.70	2.35	54.50%	5.50%	9.77%
AUPH	AURINIA PHARMACEUTICALS INC	$1.13B	1.50%	1.10%	2.71%	2.60%	0.46	4.57	88.00%	2.40%	5.22%
CPRX	CATALYST PHARMACEUTICALS INC	$2.95B	25.60%	22.00%	29.60%	330.80%	0.17	5.17	86.00%	33.30%	43.98%
NAGE	NIAGEN BIOSCIENCE INC	$610.34M	24.40%	14.70%	17.59%	94.00%	0.48	3.57	61.80%	8.60%	8.89%
RIGL	RIGEL PHARMACEUTICALS INC	$349.40M	-95.90%	12.50%	26.11%	39.20%	48.87	2.13	89.60%	9.80%	14.66%
BMRN	BIOMARIN PHARMACEUTICAL INC	$12.15B	8.00%	6.10%	8.69%	9.90%	0.24	5.33	79.70%	15.00%	19.43%
EXEL	EXELIXIS INC	$10.96B	23.80%	18.20%	26.79%	28.50%	0.31	3.64	96.50%	24.00%	31.43%
INCY	INCYTE CORP	$12.13B	0.60%	0.40%	7.87%	16.30%	0.57	2.04	92.70%	0.50%	7.19%
JAZZ	JAZZ PHARMACEUTICALS PLC	$7.10B	14.20%	4.80%	6.44%	9.10%	1.93	4.46	89.00%	13.80%	17.37%
TECH	BIO-TECHNE CORP	$7.96B	7.60%	5.80%	8.03%	14.90%	0.29	3.94	65.60%	13.20%	16.85%
CSBR	CHAMPIONS ONCOLOGY INC	$98.86M	656.70%	24.00%	59.51%	60.30%	4.60	0.99	51.60%	11.00%	10.92%
CRMD	CORMEDIX INC	$599.02M	-29.00%	-22.30%	-22.69%	-74.10%	0.40	3.39	92.70%	-41.20%	-44.37%
XERS	XERIS BIOPHARMA HOLDINGS INC	$703.51M	N/A	-16.70%	-11.96%	-8.20%	-11.91	1.67	81.90%	-27.00%	-13.11%
GMAB	GENMAB A	$14.00B	23.80%	19.50%	27.51%	64.30%	0.25	5.25	95.40%	36.40%	51.76%
HALO	HALOZYME THERAPEUTICS INC	$7.56B	138.40%	22.20%	29.89%	24.20%	4.67	7.80	84.30%	43.70%	56.65%
FOLD	AMICUS THERAPEUTICS INC	$2.30B	-35.30%	-7.40%	3.28%	3.40%	3.05	3.39	90.00%	-10.60%	3.95%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$1.77B	-77.20%	-32.80%	-41.89%	-28.50%	1.22	4.15	90.30%	-71.30%	-57.10%
HRTX	HERON THERAPEUTICS INC	$368.64M	N/A	-6.10%	-7.83%	-3.80%	-7.93	2.29	73.20%	-9.40%	-7.69%
UTHR	UNITED THERAPEUTICS CORP	$13.67B	19.30%	16.70%	22.78%	31.60%	0.14	5.46	89.00%	40.40%	53.43%
NVO	NOVO NORDISK A S	$296.70B	85.00%	26.40%	51.23%	87.20%	2.25	0.74	84.70%	34.80%	43.80%
THTX	THERATECHNOLOGIES INC	$130.58M	N/A	-5.90%	64.55%	36.10%	-3.31	1.08	79.00%	-4.20%	15.51%
PBYI	PUMA BIOTECHNOLOGY INC	$157.76M	46.10%	14.20%	31.18%	46.50%	1.32	1.54	72.10%	13.10%	15.86%
VRTX	VERTEX PHARMACEUTICALS INC	$130.83B	-3.30%	-2.40%	1.47%	2.30%	0.37	2.69	86.10%	-4.90%	2.53%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$1.97B	-3.80%	-3.00%	-1.26%	-1.90%	0.31	3.66	85.80%	-3.50%	-1.31%
ACAD	ACADIA PHARMACEUTICALS INC	$2.44B	39.50%	23.00%	32.55%	75.00%	0.62	2.38	91.50%	23.60%	26.94%
KURA	KURA ONCOLOGY INC	$529.75M	-38.50%	-30.20%	-25.00%	-37.20%	0.84	9.46	100.00%	-322.90%	-316.14%
RPRX	ROYALTY PHARMA PLC	$18.92B	8.50%	4.90%	6.39%	4.70%	0.76	1.44	100.00%	37.90%	47.91%
SRPT	SAREPTA THERAPEUTICS INC	$6.05B	19.70%	6.60%	8.07%	7.00%	1.59	4.20	83.20%	12.40%	13.71%
TGTX	TG THERAPEUTICS INC	$7.15B	12.40%	4.80%	10.19%	11.70%	1.60	6.25	88.30%	7.10%	15.08%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.69B	25.20%	16.00%	25.40%	47.70%	0.52	3.31	78.10%	20.40%	29.28%
MDXG	MIMEDX GROUP INC	$1.01B	24.30%	17.70%	26.90%	54.60%	0.37	4.21	82.80%	12.20%	16.83%
MNKD	MANNKIND CORP	$1.53B	-14.80%	6.20%	21.95%	9.90%	-6.00	3.28	73.20%	9.70%	23.99%
INVA	INNOVIVA INC	$1.17B	3.40%	1.90%	5.60%	5.40%	0.88	2.35	89.80%	6.50%	16.61%
FENC	FENNEC PHARMACEUTICALS INC	$166.67M	N/A	-0.70%	10.51%	10.60%	-8.65	6.38	93.30%	-0.90%	8.41%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.85B	N/A	-18.50%	3.50%	1.10%	-2.03	2.63	97.20%	-19.70%	2.57%
ARGX	ARGENX SE	$39.20B	17.40%	15.50%	1.58%	3.00%	0.13	7.29	-5,127.40%	19,159.20%	2,015.73%
LGND	LIGAND PHARMACEUTICALS INC	$2.12B	-0.50%	-0.40%	0.61%	1.20%	0.13	8.93	93.40%	-2.40%	3.32%
TARS	TARSUS PHARMACEUTICALS INC	$1.99B	-46.70%	-31.20%	-36.34%	-52.90%	0.68	4.43	93.00%	-63.20%	-58.87%
GLUE	MONTE ROSA THERAPEUTICS INC	$302.01M	-36.10%	-21.30%	-24.89%	-41.20%	0.97	2.41	100.00%	-96.10%	-92.74%
ABUS	ARBUTUS BIOPHARMA CORP	$679.75M	-63.40%	-48.00%	-60.11%	-82.80%	0.35	8.15	100.00%	-1,133.00%	-1,130.82%
ARDX	ARDELYX INC	$1.31B	-24.90%	-10.50%	-7.23%	-6.90%	1.52	4.58	84.80%	-11.70%	-7.75%
ALNY	ALNYLAM PHARMACEUTICALS INC	$34.08B	N/A	-6.80%	-7.71%	-7.10%	62.20	2.78	85.60%	-12.40%	-10.48%
VCEL	VERICEL CORP	$1.90B	4.00%	2.70%	2.91%	3.10%	0.48	4.23	72.60%	4.40%	4.69%
IVVD	INVIVYD INC	$75.58M	-144.70%	-99.30%	-251.60%	1,816.10%	0.92	1.63	93.60%	-669.40%	-669.42%
STOK	STOKE THERAPEUTICS INC	$527.80M	-42.20%	-33.00%	-43.90%	-158.20%	0.19	5.81	100.00%	-243.40%	-277.99%
CTMX	CYTOMX THERAPEUTICS INC	$59.59M	-146.80%	21.10%	92.32%	-1,013.20%	-265.33	1.25	100.00%	23.10%	23.24%
ASND	ASCENDIS PHARMA A	$10.34B	N/A	-39.40%	-100.58%	-66.30%	-12.16	1.17	87.80%	-104.00%	-75.13%
VRNA	VERONA PHARMA PLC	$6.14B	-89.80%	-36.10%	-26.10%	-48.40%	1.32	8.86	94.90%	-138.30%	-103.34%
KRYS	KRYSTAL BIOTECH INC	$4.89B	10.30%	9.40%	10.00%	18.10%	0.12	7.28	93.10%	30.70%	32.82%
CORT	CORCEPT THERAPEUTICS INC	$7.58B	22.70%	18.70%	19.36%	27.00%	0.24	3.35	98.40%	20.70%	20.07%
LEGN	LEGEND BIOTECH CORP	$6.41B	-15.80%	-10.10%	-9.80%	-21.80%	0.61	4.62	62.60%	-28.20%	-21.76%
TLX	TELIX PHARMACEUTICALS LTD	$5.82B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
ABEO	ABEONA THERAPEUTICS INC	$318.38M	-165.40%	-58.20%	-64.46%	-63.50%	1.47	6.08	N/A	N/A	N/A
ADMA	ADMA BIOLOGICS INC	$5.66B	85.70%	49.20%	32.24%	37.00%	0.40	5.97	51.50%	46.40%	32.75%
IMAB	I-MAB	$76.65M	-10.10%	-7.70%	-10.88%	-31.30%	0.06	20.90	N/A	N/A	N/A
XOMA	XOMA ROYALTY CORP	$287.97M	-22.10%	-8.50%	-5.64%	-5.90%	1.70	5.15	100.00%	-67.70%	-39.00%
VCYT	VERACYTE INC	$2.38B	2.10%	1.90%	2.11%	24.60%	0.11	4.73	66.90%	5.40%	5.78%
MGTX	MEIRAGTX HOLDINGS PLC	$559.08M	-161.80%	-51.60%	-64.37%	-65.50%	2.98	2.03	28.50%	-444.10%	-404.22%
ONC	BEIGENE LTD	$27.75B	-19.10%	-11.10%	-15.67%	-27.40%	0.78	1.80	84.40%	-16.90%	-15.24%
GYRE	GYRE THERAPEUTICS INC	$913.66M	19.90%	9.80%	16.44%	19.90%	0.43	3.32	96.30%	11.40%	16.46%
ENTA	ENANTA PHARMACEUTICALS INC	$129.92M	-75.50%	-27.30%	-32.38%	-29.80%	2.12	5.47	100.00%	-157.60%	-145.67%
VNDA	VANDA PHARMACEUTICALS INC	$263.01M	-3.50%	-2.90%	-4.12%	-6.80%	0.22	4.39	94.30%	-9.50%	-11.53%
DOMH	DOMINARI HOLDINGS INC	$28.81M	-35.00%	-30.70%	-33.92%	-33.10%	0.18	7.44	100.00%	-81.00%	-81.03%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.13B	-1,337.40%	-15.90%	-22.94%	-16.90%	8.87	1.26	97.00%	-41.30%	-33.71%
GOSS	GOSSAMER BIO INC	$231.77M	-117.80%	-17.40%	-16.32%	-10.20%	9.69	6.89	100.00%	-49.30%	-38.46%
PTCT	PTC THERAPEUTICS INC	$3.93B	N/A	-20.00%	-17.45%	-30.90%	-2.55	2.35	92.90%	-45.00%	-24.31%
WVE	WAVE LIFE SCIENCES LTD	$1.18B	-104.00%	-33.60%	-40.21%	128.60%	0.64	2.89	100.00%	-89.60%	-89.57%
IBRX	IMMUNITYBIO INC	$2.14B	N/A	-103.90%	-79.04%	-23.20%	-1.78	3.36	100.00%	-2,804.80%	-1,758.13%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$1.09B	-67.70%	-27.70%	-33.52%	-27.80%	1.66	2.89	59.70%	-89.10%	-82.65%
NVAX	NOVAVAX INC	$1.07B	N/A	-11.60%	-38.56%	-218.70%	-3.50	0.98	70.30%	-27.50%	-22.95%
TBPH	THERAVANCE BIOPHARMA INC	$483.33M	-29.70%	-15.60%	-13.06%	-12.30%	1.02	5.02	100.00%	-87.60%	-65.34%
CVAC	CUREVAC NV	$796.40M	28.90%	22.30%	26.24%	78.80%	0.15	7.28	80.20%	30.30%	35.82%
NTRB	NUTRIBAND INC	$76.74M	-96.40%	-85.90%	-161.26%	-3,534.70%	0.16	4.88	34.70%	-489.90%	-488.95%
MIRM	MIRUM PHARMACEUTICALS INC	$2.13B	-38.20%	-13.30%	-13.34%	-20.10%	1.97	3.10	75.80%	-26.10%	-21.55%
FHTX	FOGHORN THERAPEUTICS INC	$233.57M	N/A	-29.50%	-39.92%	-44.90%	-7.24	3.73	100.00%	-383.20%	-383.24%
MESO	MESOBLAST LTD	$1.31B	-21.30%	-15.60%	-13.73%	-79.50%	0.42	0.96	100.00%	-1,822.80%	-1,405.84%
KLRS	KALARIS THERAPEUTICS INC	$31.62M	-49.50%	-45.50%	-51.87%	-235.40%	0.05	22.63	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$1.37B	3.60%	3.10%	2.53%	3.90%	0.37	14.26	98.90%	9.00%	9.29%
AKBA	AKEBIA THERAPEUTICS INC	$569.32M	N/A	-31.80%	-36.65%	-77.90%	-5.49	1.41	60.60%	-43.30%	-31.98%
APLS	APELLIS PHARMACEUTICALS INC	$2.41B	-79.40%	-22.50%	-22.35%	-22.40%	2.87	4.25	84.90%	-25.30%	-20.01%
ANAB	ANAPTYSBIO INC	$681.42M	-272.90%	-32.10%	-33.13%	-45.60%	5.83	9.51	100.00%	-159.10%	-159.10%
CLLS	CELLECTIS SA	$46.06M	-29.40%	-9.50%	-6.97%	-9.00%	1.93	1.73	100.00%	-74.70%	-30.78%
ZVRA	ZEVRA THERAPEUTICS INC	$396.67M	-221.30%	-63.40%	-57.47%	-111.00%	3.49	2.53	68.60%	-446.90%	-350.62%
TVTX	TRAVERE THERAPEUTICS INC	$1.85B	-1,091.50%	-55.60%	-78.87%	-46.80%	9.06	2.08	96.70%	-137.90%	-133.05%
TLSA	TIZIANA LIFE SCIENCES LTD	$140.20M	-140.90%	-91.50%	-305.44%	-509.70%	1.20	1.12	N/A	N/A	N/A
NKTR	NEKTAR THERAPEUTICS	$147.95M	-150.60%	-35.20%	-37.57%	-26.10%	4.00	4.26	68.80%	-120.90%	-92.54%
BNTX	BIONTECH SE	$24.99B	-3.40%	-3.00%	-3.25%	-6.50%	0.16	7.45	80.30%	-24.20%	-23.64%
CANF	CAN-FITE BIOPHARMA LTD	$9.76M	-134.90%	-82.50%	-111.49%	-259.30%	0.68	4.38	100.00%	-1,169.10%	-1,169.14%
BNTC	BENITEC BIOPHARMA INC	$318.71M	-44.30%	-41.00%	-27.51%	733.40%	0.04	25.48	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$496.71M	-44.10%	-25.50%	-13.34%	-54.20%	0.03	44.63	100.00%	-3,223.40%	-2,650.04%
PULM	PULMATRIX INC	$24.14M	-73.30%	-56.50%	-106.05%	-204.20%	0.11	10.68	100.00%	-122.50%	-122.46%
CAPR	CAPRICOR THERAPEUTICS INC	$580.09M	-66.40%	-46.10%	-27.08%	-94.50%	0.17	7.77	100.00%	-181.70%	-181.71%
INO	INOVIO PHARMACEUTICALS INC	$71.13M	-128.70%	-88.80%	-137.50%	-150.90%	0.65	2.77	100.00%	-49,254.30%	-49,172.60%
RGNX	REGENXBIO INC	$481.33M	-69.90%	-41.60%	-59.11%	-47.30%	0.80	2.69	59.70%	-272.50%	-257.35%
PTGX	PROTAGONIST THERAPEUTICS INC	$2.81B	47.70%	42.50%	40.07%	65.90%	0.10	12.48	100.00%	63.30%	64.32%
MRUS	MERUS NV	$3.14B	-35.20%	-28.50%	-34.21%	-79.70%	0.21	6.54	100.00%	-595.90%	-658.58%
MDGL	MADRIGAL PHARMACEUTICALS INC	$7.37B	-57.50%	-43.40%	-51.69%	-66.80%	0.38	6.10	96.50%	-258.60%	-250.49%
LXRX	LEXICON PHARMACEUTICALS INC	$264.25M	-93.90%	-56.80%	-73.00%	-58.20%	1.05	5.44	98.00%	-644.80%	-594.65%
HURA	TUHURA BIOSCIENCES INC	$165.11M	-348.90%	-240.00%	-119.86%	42,031.10%	0.37	3.68	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$168.01M	-103.60%	-89.60%	-29.01%	-246.70%	0.04	26.37	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.